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Virus TranscriptionThe vaccinia virus E6R gene encodes a late protein that is packaged into virion cores. A temperature-sensitive
mutant was used to study the role of this protein in viral replicative cycle. Cts52 has a P226L missense
mutation in the E6R gene, shows a two-log reduction in plaque formation, but displays normal patterns of
gene expression, late protein processing and DNA replication during infection. Mutant virions produced at
40 °C were similar in their morphology to wt virions grown at 40 °C. The particle to infectivity ratio was 50
times higher in puriﬁed Cts52 grown at 40 °C when compared to the mutant grown at permissive
temperature. In vitro characterization of Cts-52 particles grown at 40 °C revealed no differences in protein
composition or in DNA content and the mutant virions could bind and enter cells. However, core particles
prepared from Cts52 grown at 40 °C failed to transcribe in vitro. Our results show that E6 in the virion has
either a direct or an indirect role in viral transcription.Inc.Published by Elsevier Inc.Introduction
Vaccinia virus (VACV), the prototypic member of the family
Poxviridae, has a 192-kb genome, encoding more than 200 polypep-
tides that function in viral transcription, genome replication, virion
assembly, and host defense (for a review, see Moss, 2007). Over one
third of the virus-coded genes are incorporated into the virion
particle, including enzymes involved in early viral RNA synthesis. The
vaccinia virion is a membraned, brick-shaped particle with a unique
and complex internal structure featuring a biconcave core and
ﬂanking lateral bodies (for a review, see Condit et al., 2006). The
replicative cycle of VACV occurs exclusively in the cytoplasm and the
virions utilize their own encapsidated transcription apparatus to
initiate the process. Throughout viral replicative cycle virus genes are
expressed in a controlled cascade where each stage of the cycle
depends on the completion of the previous phase (Moss, 1994; Condit
and Niles, 2002).
Vaccinia virion assembly is a complex and poorly understood
process that is of signiﬁcant interest (Condit et al., 2006). The ﬁrst
evidence of virus morphogenesis is the formation of virus “factories”,
which appear soon after virus penetration, the expression of early
virus genes, and the ﬁrst rounds of viral DNA replication. Electron
microscopy of infected cells reveals factories as speciﬁc sites in the
cytoplasm depleted of cellular organelles and sometimes delimited by
ER-derived cisternae; these factories represent the location of viralDNA replication (Tolonen et al., 2001). The appearance of crescents,
membrane-like structures, marks the initial steps of viral morpho-
genesis, followed by formation of enclosed membrane vesicles known
as immature virions (IV) (Dales and Mosbach, 1968; Risco et al.,
2002). During the ﬁnal stages of IV formation, viral DNA is
encapsidated to form dense substructures within the IV, yielding
immature virions with nucleoids, or IVN (Dales, 1963; Ericsson et al.,
1995). The ﬁnal step of morphogenesis requires proteolysis of some
viral proteins and comprises reorganization of the internal and
external particle structure, resulting in the formation of an infectious
mature virion (MV) (Dales and Siminovith, 1961; Byrd and Hruby,
2006). The majority of MV remain in the cytoplasm; however, a small
fraction are transported through the trans-Golgi apparatus and thus
acquire a two new membrane layers forming wrapped virions (WV)
(Sodeik et al., 1993; Smith and Vanderplasschen, 1998). Finally, WV
move to the periphery of the cell, lose one membrane layer by fusion
with the plasma membrane and are released as an alternate, double
membraned form of infectious virus, the extracellular virion (EV)
(Smith and Law, 2004). Speciﬁc functions and localizations within the
particle have been determined for less than half of the over 70
proteins in the virion.
Recently, our group has completed the mapping and preliminary
characterization of temperature-sensitive alleles in the Condit/Dales
collection of VACV mutants (Kato et al., 2008). Among the genes
affected by the mutants in this collection, E6R is the least well
characterized, described only as a core protein and with no other
function ascribed to the gene. Three ts mutants, Cts52, Dts40, and
Dts81, have been placed in the same complementation group and
Fig. 1. One-step growth and DNA replication in cells infected with wt and mutants in the
E6R gene. (A) BSC40 cells were infected at MOI=10 pfu/cell with wt (VACV-WR) or
Cts52 incubated at 31 or 40 °C. At indicated times, post-infection samples were removed
and virus yields were determined by plaque titration at 31 °C. (B) BSC40 cells were
infected wt (VACV-IHD-W) or Dts41or Dts80 as described above. Virus yield was
determined by plaque assay at 31 °C after 24 and 48 hpi. (C) BSC-40 cells were infected
wt (VACV-WR) or Cts52, incubated at 31 or 40 °C as described above. At indicated times
post-infection, cell extractswere prepared and applied in triplicate on nylonmembranes,
and hybridization to a 32P labeled vaccinia virus DNA probe was performed as described
under Materials and methods. The numbers (arbitrary units) express the average value
of three different samples. wt-31 °C (♦), wt-40 °C (▪), Cts52-31 °C (▴), Cts52-40 °C (●).
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characterization of Cts52. Our results show that under non-permissive
conditions the mutant virus displayed normal patterns of gene
expression, late protein processing, and DNA replication. Virions
produced at the non-permissive temperature were similar in
morphology to wt virions produced at 40 °C, but the particle to
infectivity ratio was 50 times higher in puriﬁed Cts52 grown at 40 °C
when compared to the mutant grown at permissive temperature.
Puriﬁed Cts52 particles grown at 40 °C did not reveal any differences
in protein composition or in the quantity of DNA encapsidated and
were able to enter the cell. However, cores prepared from Cts52
grown at 40 °C failed to transcribe in vitro.
Results
Characteristics of the E6R gene
The VACV E6R gene is 1704 nucleotides in length and encodes a
567 amino acid protein of MW 66,670 that is present in puriﬁed
virions. It is the 13th most abundant protein in the virion and it is
conserved among all the Chordopoxvirinae (Chung et al., 2006). A
distant homolog with 20.4% identity and 37.9% similarity has been
described in Melanoplus sanguinipes entomopoxvirus (Afonso et al.,
1999). A phylogenetic analysis of the sequenced E6 genes groups all
the Orthopoxviruses in the same sub-clade (data not shown). It is also
noteworthy that viruses grouped using E6R gene homology clustered
into sub-clades which correlate precisely with Chordopoxvirinae
genera. DNA sequence analysis predicts that E6R is a late gene: the
translation initiation ATG codon is preceded by a TAAAA late gene
promoter signature and the body of the gene contains three early gene
transcription termination sequences. Our own results conﬁrm that E6
is expressed late during infection since in the absence of DNA
replication, we were not able to detect its presence by western blot
(data not shown). The three E6R ts mutants described here are in the
same complementation group and have the following mutations:
Cts52: P226L; Dts 41: P150L; and Dts 80: L260F (Kato et al., 2008).
One-step growth, DNA replication, and protein synthesis in E6R ts
mutant infected cells
To analyze the growth characteristics of Cts52, we performed one-
step growth experiments. BSC40 cells were infectedwith anMOI of 10
with either wild type (wt) or mutant virus and incubated at
permissive (31 °C) and non-permissive temperatures (40 °C). At
different times post-infection, infected cells were harvested and the
amount of virus in each sample determined by plaque assay. As shown
in Fig. 1A, wt VACV (WR strain) was able to grow at both
temperatures, producing nearly 800 pfu/cell at 31 °C and almost
400 pfu/cell at 40 °C. On the other hand, cells infected with Cts52 at
31 °C produced 100 pfu/cell but at 40 °C only 2 pfu/cell were formed.
This result represents a reduction of almost two logs in the production
of infectious virus at the non-permissive temperature.
A similar effect was observed when BSC40 cells were infected with
the two other ts mutants in this same complementation group, Dts41
and Dts80. Since these mutants were in the VACV IHD-W background,
this strain was used as the wt virus control. As shown in Fig. 1B, wt
virus grown at the permissive temperature produced 55 and 114 pfu/
cell after 24 and 48 h of infection respectively, and at 40 °C, the wt
virus produced 42 and 16 pfu/cell after 24 and 48 h of infection. The
two Dts mutants presented a similar pattern of one-step growthwhen
analyzed under permissive and non-permissive conditions. At 31 °C,
Dts41 generated 88 and 100 pfu/cell after 24 and 48 h of infection,
respectively, and Dts80 produced 140 and 180 pfu/cell during the
same period. However, under non-permissive conditions, the total
amount of infectious particles in Dts41 infections was reduced to 0.6
and 0.7 pfu/cell and Dts80 was reduced to 1.4 and 0.4 pfu/cell after
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reduction in the titer of infectious particles produced at 40 °C
compared to 31 °C, similar to what was described for Cts52. Since
Cts52, Dts41, and Dts80 comprise a single complementation group
and display similar growth characteristics, most of the remaining
phenotypic characterization was focused on Cts52.
Since mutants in the E6R gene were not able to produce infectious
progeny, we next determined whether Cts52 was altered in synthesis
of macromolecules. DNA accumulation was measured by infecting
BSC40 cells with wt or Cts52 viruses and incubating at 31 and 40 °C. At
different times after infection, the cells were harvested and the cell
lysates were applied to a slot-blot membrane, hybridized to a 32P-
labeled vaccinia DNA probe, and quantiﬁed using a phosphor-imager.
The data presented in Fig. 1C show that both wt and Cts52 viruses
were able to accumulate DNA to the same level regardless the
temperature of incubation. Thus, the temperature sensitivity of Cts52
does not result from a defect in DNA replication.
Next, we investigated gene expression in Cts52 virus infections
under non-permissive conditions by analyzing the global synthesis of
virus protein, the processing of one of themajor core proteins, and the
accumulation of the E6 protein. To evaluate the global proﬁle of
protein synthesis, BSC40 cells were infected with wt and Cts52 virus
at permissive and non-permissive temperatures. At different times
after infection, total protein synthesis was analyzed by metabolic
labeling with 35S-methionine in a 30-min pulse. The 35S-labeled
proteins were separated by SDS–PAGE and analyzed by autoradiog-
raphy. The patterns of protein synthesis in wt and mutant infections
incubated at both permissive and non-permissive conditions were
indistinguishable from one another (Fig. 2a). At 3 h post-infection,
early viral protein synthesis is apparent concomitant with a decrease
in the synthesis of host proteins. By 6 h post-infection, cellular protein
synthesis had been reduced to a minimal level and late viral protein
synthesis is observed and persists throughout the course of the
infection. Thus, Cts52 displays no apparent defect in protein synthesis
at the non-permissive temperature which could account for its
temperature sensitivity.Fig. 2. Virus protein synthesis, processing of p4a, and accumulation of E6. BSC40 cells wer
different times post-infection, the cells were pulse-labeled with 35S methionine, cells lys
autoradiographed. The virus used in the infection and the hpi of the pulse label is indicated at
and the approximate molecular weights, in kDa, are indicated to the right of each autoradio
separated by SDS–PAGE, transferred to a nitrocellulose membrane and probe against viral pr
indicated on the top of the ﬁgure, the estimated molecular weights in kDa are indicated onThe cleavage of speciﬁc structural proteins is an important process
in VACV morphogenesis and a mandatory step in the formation of an
MV (Byrd and Hruby, 2006). One of the proteins that is processed
during morphogenesis is the product of the A10L gene, p4a. This gene
is expressed as a 102-kDa precursor that it is cleaved into three new
proteins of 62, 9, and 23 kDa. To analyze if A10 was processed during
Cts52 infection, BSC40 cells were infected with wt and mutant viruses
at 31 or 40 °C and after 12 and 24 h of infection the cells were
harvested, proteins were separated by SDS–PAGE, transferred to a
nitrocellulose membrane, and the western blot probed with antibody
to the A10 protein. In Fig. 2b, we show that wt and Cts52 viruses
grown at permissive and non-permissive temperatures accumulate
the A10 protein with no visible difference. Furthermore, the
processing of the 102-kDa precursor p4a protein into the 62-kDa 4a
mature form was not affected. This result demonstrates that the
protein processing in Cts52 grown at 40 °C was not impaired.
To investigate the accumulation of E6 protein during Cts52
infection under non-permissive conditions, western blots of infected
cell extracts prepared as described above were probed with antibody
to the E6 protein. The accumulation of E6 was very similar in both wt
and mutant infections and dependent on the temperature of
incubation (Fig. 2c). At 31 °C, both wt and Cts52 accumulated less
E6 when compared to the amount present in infected cells when the
viruses were grown 40 °C. Nevertheless, equivalent amounts of E6
protein accumulated in wt and Cts52 infections incubated at 40 °C.
This result shows that the temperature sensitivity of Cts52 is not
associated with a reduction in the amount of E6 protein.
Electron microscopic analysis of mutants in the E6 gene grown at the
non-permissive temperature
VACV morphogenesis begins after viral DNA replication, extends
throughout infection, and is sufﬁciently asynchronous such that the
full spectrum of assembly intermediates and mature virus forms can
be detected at late times of infection using transmission electron
microscopy (Condit et al., 2006). To determine whether viruse infected at MOI=10 pfu/cell, with wt or Cts52 and incubated at 31 or 40 °C. (a) At
ates were prepared, the proteins separated on SDS–PAGE, and gels were dried and
the top of each column. The incubation temperature is indicated to the left of the ﬁgure
gram. (b, c) At indicated times after infection, cells lysates were prepared, the proteins
oteins: p4a/A10 (b) or E6 (c). The virus, the temperature of incubation, and the hpi are
the left, and the arrow on the right represents the relevant proteins.
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with VACV wt or Cts52 mutant viruses, incubated at 31 and 40 °C, and
processed for electron microscopy after 24 and 48 h of infection
(Fig. 3). Viral membrane crescents, IV, IVN, and normal looking MV
were observed in wt and Cts52 virus infected cells incubated at
permissive temperature (data not shown). As shown in Fig. 3A, wt
virus grown at 40 °C for 24 h produced normal progeny as has been
well documented (Hooda-Dhingra et al., 1989; Kato et al., 2004).
Cts52 grown at the non-permissive temperature produced MV-like
particles that were indistinguishable from wt virions (Figs. 3B–D).
Speciﬁcally, we were able to identify crescents, IV, IVN, and MV-like
particles. Some of the MV-like particles observed in Cts 52 infections
grown at 40 °C appeared round rather than the expected ovoid shape
and possessed lucent centers rather than an electron dense core,
suggesting that Cts52 particles formed at the non-permissive
temperature may not be completely normal in structure. However,
these same features are apparent among MV in wt infections
incubated at 40 °C (Fig. 3A); thus, we suspect that many if not all of
these abnormalities may result generally from the high temperature
incubation and are not speciﬁcally associated with the temperature-
sensitive mutation in Cts52. In short, we were not able reliably to
distinguish the particles formed in Cts52 infections from those formed
in wt infections. Likewise, BSC40 cells infected with Dts41 and Dts80
grown at 40 °C were able to form particles with a morphology that
was similar wt virus grown at 40 °C (Figs. 3E and F), consistent withFig. 3. Electron micrographs of wt and mutant infected cells. BSC40 cells were infected with
(D–F) and processed for electron microscopy as described in Materials and methods. (A)
C=crescents; N=nucleus; F=DNA factories.previous observations (Dales et al., 1978). These results show that the
ts E6R mutants were able to morph into particles that resemble MV
but are non-infectious.
Characteristics of the Cts52 puriﬁed particles
To obtain better insight into the mutant particles, BSC40 cells were
infected with wt and Cts52 viruses and incubated at 40 °C for 24 h or
at 31 °C for 48 h. Infected cells were then disrupted and the virus was
puriﬁed using velocity sedimentation on sucrose gradients. As shown
in Table 1 no major difference was observed in the yield for each virus
grown at the same temperature of incubation. At 31 °C, more than
1000 particles were produced in each infection while at 40 °C
approximately 700 particles were formed per cell. However, a
difference in the speciﬁc infectivity (particles/pfu) was evident
when we compared the same virus grown under different conditions.
In this comparison, the speciﬁc infectivity for wt was 1.9 times lower
for particles formed at 40 °C while for Cts52 the speciﬁc infectivity
was reduced 50 times for viruses grown under non-permissive
condition. Cts52 grown at the permissive temperature was nearly 11
times less infectious than the wt grown under the same conditions
and the mutant virus grown at 40 °C was more than 350 times less
infectious than the wt grown at the same temperature. Thus, Cts52
particles grown at 40 °C, while normal in appearance, are severely
reduced in infectivity.wt or mutant virus at an MOI=10 pfu/cell, incubated at 40 °C for 24 (A–C) and 48 h
wt; (B–D) Cts52; (E) Dts41; (F) Dts80. IV=immature virions; MV=mature virions;
Table 1
Characteristics of puriﬁed wt and mutant Vaccinia virus particles.
Virus temperaturea Yield (particles/cell)b Infectivity (particles/pfu)
Wt-31 °C 1308 25
Wt-40 °C 732 47.5
Cts52-31 °C 1464 293
Cts52-40 °C 696 14,745
a Wt and Cts52 were isolated from high MOI infections. Viruses grown at 40 °C were
incubated for 24 h; viruses grown at 31 °C were incubated for 72 h.
b Calculated from an A260nm reading of puriﬁed virus, assuming 1 A260nm=1.2×1010
particles/ml.
225O. Boyd et al. / Virology 399 (2010) 221–230To characterize the macromolecular content of the virions, we
compared the DNA and protein composition of puriﬁed virions grown
under different conditions. To measure the amount of DNA, different
quantities of puriﬁed viruses were blotted onto a nylon membrane,
hybridized with 32P-labeled VACV DNA HindIII E fragment, and
quantiﬁed using a phosphor-imager. The phosphorimage presented in
Fig. 4A and quantiﬁed in Fig. 4B demonstrates that the amount of DNA
present in the virions was comparable among all samples, indepen-
dent of the growth condition. The protein proﬁle of virions was
examined using two different particle concentrations analyzed by
SDS–PAGE and stained with Coomassie blue. The result presented in
Fig. 4C shows that the protein proﬁles among the viruses grown at
different temperatures were indistinguishable.
After treatment of puriﬁed VACV with a non-ionic detergent and
a reducing agent, the disrupted virions can be separated byFig. 4. Analysis of the DNA content and protein composition of puriﬁed wt and mutant pa
determined by A260nm and indicated on the top of each lane were applied onto a nylon mem
with a phosphor-imager apparatus, and the data were normalized and graphed as describe
analyzed by SDS–PAGE and Coomassie blue staining. The amount of virions determined by A
is indicated on the left of the gel. (D) Partition of puriﬁed virions into core and membrane fr
was resuspended in core buffer and processed as described under Materials and methods.
weight is indicated to the left of each row, the virus sample probed is indicated on the top of
wt grown at 40 °C; Cts-31, Cts52 grown at 31 °C; Cts40, Cts52 grown at 40 °C.centrifugation in soluble and particulate fractions (Ichihashi et al.,
1984). The soluble fraction is composed of proteins that constitute
the virus membrane while the particulate fraction contains proteins
and DNA from the virus core. The E6 protein has been designated as a
core protein. To analyze the presence of E6 in virions and the
integrity of the mutant particles, puriﬁed viruses were disrupted
with NP40 and DTT, core and membrane fractions were separated by
centrifugation, and the presence of speciﬁc virion proteins was
analyzed by western blot. The results presented in Fig. 4D show no
alteration in the amount E6 protein contained in virions grown
under different conditions. We also did not observe any major
difference in the content of other virion proteins analyzed. The core
proteins H4, a subunit of the early RNA polymerase, D1 and D12,
large and small subunits capping enzyme, L4, an RNA and ssDNA
binding protein, E8, an essential virion core protein, and the
membrane protein A27 were present in similar amounts and
partitioned in the predicted virion fraction. Thus, the data presented
so far suggest that the defect in Cts52 particles produced at 40 °C was
not directly related to the DNA or protein content of the virions or to
the integrity of the particles.Cts52 can bind and enter BSC40 cells
To investigate whether puriﬁed Cts52 grown at the non-
permissive temperature was competent to initiate an infectious
cycle, we examined the ability of the virus to bind and penetrate cellsrticles. (A) Samples of puriﬁed wt and Cts52 were diluted and the amount of virions
brane, processed and hybridized to 32P VACV DNA fragment. (B) The blot was analyzed
d in Materials and methods. (C) The polypeptide composition of puriﬁed virions was
260nm is indicated on the top of each lane and the approximate molecular weight marker
action and Western blot analysis. The 0.06 A260nm units (∼0.7 μg) of each virion sample
The gene product corresponding to each antiserum used with the predicted molecular
the ﬁgure. C=core fraction, M=membrane fraction. Wt31, wt grown at 31 °C; Wt-40,
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infecting BSC40 cells for 1 h at 4 °C. After this period, the monolayer
was washed to remove the un-adsorbed virus and the monolayerFig. 5. Analysis of the binding and entry process of wt and mutant virions. BSC40 cells were
31 °C (A, B, E, F) or 40 °C (C, D, G, H). The cells were processed and stained for viral membran
with DAPI (blue). The cells were analyzed by confocal microscopy as described in Materialprocessed for immunoﬂuorescence. The presence of virus associated
with the cell membrane was detected by labeling the cells with anti-
A27 antibody, using a ﬂuorescence confocal microscope. As can beinfected with MOI=1000 particles of wt (A, C, E, G) or Cts52 (B, D, F, H) virus grown at
e protein A27 (green) (A–D) or viral core protein A4 (red) (E–H), and DNA was stained
s and methods.
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and non-permissive temperatures were able to bind to cells. The
entry process was analyzed by infecting BSC40 as described above
but after removing the un-adsorbed viruses, media containing
cycloheximide was added to the monolayer and the cells were
incubated for 2 h at 31 °C. Infected cells were then processed as
described and the presence of viral cores inside the cells was
determined by labeling the monolayer with anti-A4 antibody, a core-
speciﬁc antibody that detects uncoated virions. The result presented
in Figs. 5E–G showed that both wt and Cts52 grown at permissive
and non-permissive temperature were able to enter the cells with no
major differences. The identiﬁcation of the A27 membrane protein
attached to the cell and the A4 core protein in the cytoplasm of the
cell shows that the Cts52 mutation did not interfere with binding,
uptake, or uncoating of virions.
During the ﬁrst hour of infection, cells go through a profound
transformation in their morphology in a phenomenon described as
cytopathic effect (CPE). This effect is characterized by the induction of
cell rounding, inhibition of host RNA and protein synthesis, and death
of the infected cells (Bablanian et al., 1978; Tsung et al., 1996). To
analyze whether Cts52 grown at 40 °C was able to induce CPE, BSC40
cells were infected for 1 h at 4 °C. After this period, the unabsorbed
virus was removed, fresh media were added, cells were incubated for
6 h at 31 °C, and the induction of CPE was observed by differential
interference contrast microscopy and by confocal microscopy labeling
the cells with DAPI and phalloidin. The results showed that at this
time wt viruses grown at both temperatures and Cts52 grown at 31 °C
were able to induce intense CPE in infected cell (data not shown). In
all three situations, the cells were rounded, there was a rearrange-
ment of the actin cytoskeleton, and DNA factories were observed in
the cytoplasm. On the other hand, in cells infected with Cts52 grown
at 40 °C, the cells appeared slightly detached from each other but few
cells showed cytoplasmic retraction, and in most cells the actin
cytoskeleton did not appear to be rearranged, and no DNA factories
were observed (data not shown). These results suggest that althoughFig. 6. RNA synthesis directed by puriﬁed wt andmutants particles. (A) Total core RNA synth
DTT treatment, incubated in a reaction mixture that contains [α32P] CTP, unlabelled GTP, AT
were removed, and the acid precipitable radioactivity was determined in a liquid scintillat
extrusion from cores. Puriﬁed virions grown at 31 °Cwere activated for RNA as described abo
separated by centrifugation as described in Materials and methods. wt-core (▪); wt-superCts52 virus grown at the non-permissive temperature was able to
enter BSC40 cells, the virus was unable to initiate replication.
Cts52 virions are defective in core transcription
All the enzymes necessary for RNA synthesis, addition of a 5′
mRNA cap and a 3′ poly-A tail, and extrusion of the viral transcript
from the core are packaged in the virion (Moss, 1994). Virions need to
be permeabilized with NP40 and DTT to transcribe the DNA and
extrude the RNA from the core. To test the ability of permeabilized
virions to synthesize RNA, puriﬁed virions were permeabilized with
NP40 and DTT and incubated with a mixture of the four ribonucle-
oside triphosphates as described in Materials and methods. The result
presented in Fig. 6A shows that wt virions grown at permissive or
non-permissive temperatures were able to synthesize RNA at the
same rate. Cts52 viruses grown at 31 °C showed linear synthesis of
RNA up to 10min, and after this time the rate of transcription declined
and ceased after 30 min. Cts52 virions grown at 40 °C were unable to
synthesize RNA.
One possible explanation for the observed cessation of transcrip-
tion in Cts52 virions grown at 31 °C is inhibition of RNA extrusion
from the virions. The release of the newly synthesized RNA from cores
is an essential step for maintenance of continuous transcription in
permeabilized virions. Under certain assay conditions, if RNA
accumulates in the core, RNA synthesis will cease (Shuman and
Moss, 1989). To analyze whether RNA extrusion was affected in Cts52
virions grown at 31 °C, permeabilized cores were incubated in the
presence of ribonucleoside triphosphates. At indicated times, an
aliquot of the reaction was removed, the core and soluble fractions
were separated by centrifugation, and the amount of RNA present in
both fractions was determined. As shown in Fig 6B, the RNA
synthesized bywt viruses was distributed preferentially in the soluble
fraction and a small proportion stayed in the insoluble fraction.
Similar to the wt, the RNA synthesized by Cts52 virions was released
into the soluble fraction and only a small amount remained in theesis. Puriﬁed virions grown at different temperature were permeabilized with NP40 and
P, and UTP, MgCl2 as described in Materials and methods. At indicated times, samples
ion counter. wt-31 °C (♦); wt-40 °C (▪); Cts52-31 °C (●); Cts52-40 °C (▴). (B) RNA
ve. At indicated times, samples were removed and the core and the soluble fraction were
natant (♦); Cts52-core (▴); Cts-52-supernantant (●).
Fig. 7. Western blot analysis of the RNA polymerases subunits in wt and mutants
particles. 0 .06 A260nm units (∼0.7 μg) of each virion sample was resuspended in SDS
sample buffer and processed as described under Materials and methods. The gene
product corresponding to each antiserum used is indicated to the left of each row, the
virus sample probed is indicated on the top of the ﬁgure. The core protein A10 was used
as a gel loading control.
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reduced as the incubation proceeded.
The inability of Cts 52 to synthesize RNA could also be related to a
reduction or absence of RNA polymerase associated with the core
(Zhang et al., 1994). To analyze the presence of the RNA polymerase
subunits, puriﬁed virions were solubilized in SDS sample buffer, the
proteins separated by SDS–PAGE, and the presence of RPO 147(J6),
RPO 132(A24), and RPO 35 (A29) was determined by western blot. As
shown in Fig. 7, both wt and Cts52 viruses grown under permissive
and non-permissive conditions contain equivalent amount of these
RNA polymerase subunits associated with the particles. Therefore, the
inability of Cts 52 to synthesize RNA is not directly related to the
amount of RNA polymerase associated with the viral particle.
Discussion
We have conducted a phenotypic analysis of temperature-
sensitive mutants whichmap to the vaccinia virus E6R gene, encoding
a virion core protein. Mutants in three different ts alleles in two
different virus strains all present similar phenotypes under non-
permissive conditions, namely production of mature virions (MV)
that are morphologically similar to wt virions grown at 40 °C, but
which are nevertheless non-infectious. Detailed analysis of one allele,
Cts52, reveals that viral gene expression, DNA replication, and
processing of virion structural protein precursors is unimpaired in
mutant infections, that the non-infectious virions produced can bind
and enter cells, but that they are defective in an in vitro core directed
transcription reaction. Thus, the most likely explanation for the
reduced infectivity of the virions produced under non-permissive
conditions is that they are unable to direct early viral gene expression
after entering cells. The E6R gene has no homologs outside of the
family Poxviridae and no known motifs suggestive of a speciﬁc
function. Mutants in three other poxvirus core protein genes, L3L, L4R,
and E8R, present a similar phenotypic proﬁle, namely production
under non-permissive conditions of typical pox virions that are
defective in virion transcription (Wilcock and Smith, 1994, 1996;
Resch and Moss, 2005; Kato et al., 2007). In these cases as well,
bioinformatic analysis provides no insights into the function of the
gene products. The next most fundamental question concerning the
function of these genes is whether they play a direct role in the virion
core transcription reaction or whether they play a subtle role in virion
structure the impacts indirectly on the virion transcription reaction.
Studies with inducible knockout mutants in the E6R gene suggest
a possible role for E6 in virion assembly or structure. Speciﬁcally, in
the absence of E6 protein, virus assembly is defective in association
of viroplasm with membrane crescents, such that normal IV, IVN, and
MV are absent and membrane crescents and unencapsidated
viroplasm accumulate (Resch et al., 2009; Boyd et al., 2010). While
such a phenotype might on the surface suggest a role for E6 instructure or assembly, it is noteworthy that defects in enzymes that
play a known role in transcription can also result in virion assembly
phenotypes. Speciﬁcally, temperature-sensitive alleles in either
subunit of the mRNA capping enzyme and inducible knockout alleles
in either subunit of VETF, the viral early transcription initiation
factor, are defective in MV formation and accumulate IV and IVN
(Carpenter and DeLange, 1991; Hu et al., 1996; Hassett et al., 1997;
Hu et al., 1998). These studies suggest that virus assembly is coupled
to proper assembly of the virion transcription complex. Thus, the
observation of a morphogenesis phenotype for any given mutants
does not exclude the possibility that the gene in question has a direct
role in virion transcription.
Mutants in several genes with known or likely roles in virion
transcription and/or RNA metabolism present phenotypes similar or
identical to the E6R ts mutants described here. These include
mutants affecting H4 (rap94), the early gene transcription speciﬁcity
subunit of the viral RNA polymerase; H1, a tyrosine/serine protein
phosphatase; H6, a DNA topoisomerase; and I8, an RNA helicase
(Kane and Shuman, 1992; Zhang et al., 1994; Liu et al., 1995; Gross
and Shuman, 1996; Da Fonseca and Moss, 2003). In each case in
mutant infections under non-permissive conditions, non-infectious
virions are produced which are morphologically indistinguishable
from wt virions by electron microscopy. Thus, the phenotype of the
E6R mutants is not inconsistent with a direct role of E6 in the virion
transcription reaction.
Previous characterization of mutants in the A3L gene demon-
strates clearly that the virion transcription reaction may be compro-
mised by defects in virion structure. The A3L gene encodes a major
virion structural protein that is thought to be a component of the
virion core wall. Temperature-sensitive mutants in A3L produce
morphologically aberrant MV that contain a wt complement of virion
proteins but are defective in transcription, despite encapsidation of
active transcription enzymes (Kato et al., 2004). While A3 mutants
MV are obviously structurally aberrant, othermutants with signiﬁcant
known defects in virion protein composition appear deceptively
normal using conventional electron microscopic techniques. Specif-
ically, the H4L (rap94) mutant virions described above lack all of the
major known or suspected enzymes involved in early viral transcrip-
tion, including the viral RNA polymerase, the capping enzyme/
termination factor, the poly(A) polymerase large subunit, DNA-
dependent ATPase I, RNA helicase, and topoisomerase, and yet these
virions are indistinguishable from wt virions using conventional
electron microscopy (Zhang et al., 1994). Application of higher
resolution electron microscopy techniques or approaches to con-
trolled degradation of virions may yet reveal structural defects in
virions produced in E6R infections or infections with phenotypically
similar mutants in genes such as E8R, L3L, and L4R (Ichihashi et al.,
1984; Szajner et al., 2005; Heuser, 2005). Based on the precedent set
by A3L mutant infections, such structural defects could impact
indirectly on virion core directed transcription.
Lastly, we must consider the intriguing possibility that E6 and
other vaccinia virion core proteins might play a dual role in
structure and transcription. Precedent for this concept is ﬁrmly
established through studies of the reovirus virion, showing that
several RNA metabolism enzymes, notably the viral RNA polymerase
and mRNA capping enzymes, are integral components of the virus
capsid (Schiff et al., 2007). It seems not unlikely that elements of the
vaccinia virion substructure, for example the core wall, may play
dual roles in RNA metabolism and virion core structure. This seems
particularly likely in the case of a gene such as E6R, in which
inducible knockout mutants result in a morphogenesis phenotype
while temperature-sensitive mutants result in production of
transcription defective virions.
In summary, the phenotypic characterization of E6R mutants
presented here is consistent with a role for E6 in either virion
structure, transcription, or both. Precise deﬁnition of E6 function
229O. Boyd et al. / Virology 399 (2010) 221–230awaits further studies that include higher resolution examination of
the substructure of the vaccinia virion.
Materials and methods
Virus, cell culture, plaque assay, one-step growth
Wild-type vaccinia virus strains WR and IHD-W were used as
controls for the studies of the temperature mutants Cts52, Dts41, and
Dts80 (Kato et al., 2008). Throughout this work, viruseswere grown in
BSC40 cells, an African green monkey cell line. The methodology for
cell culture, virus infection, puriﬁcation, plaque assay, and one-step
growth have been described before (Condit and Motyczka, 1981;
Condit et al., 1983; Kato et al., 2004). The non-permissive temperature
for analysis of ts mutants was 39.7 °C but in the text is designated as
40 °C for simplicity.
Analyses of VV DNA by slot-blot hybridization
BSC-40 cells were infected with VACV and at different times post-
infection cells were harvested and extracts were prepared and
processed as described previously (Damaso et al., 2002). For
quantitation, the blots were analyzed with a phosphor-imager
apparatus (Storm 860, GE Healthcare) and the average of the read
of the triplicates was calculated and plotted. For the analysis of the
DNA content present in puriﬁed virions, the data obtained from the
phosphor-imager were normalized for the same amount of virus and
an average number was calculated and plotted.
Metabolic labeling of viral proteins
For metabolic labeling of proteins, infected cells were incubated
with100 μCi/ml of 35S-labeled amino acids mixture (ProMix; GE
Healthcare) in a methionine free media for 30 min. After this period, a
cell extract was prepared, proteins separated in a sodium dodecyl
sulfate–polyacrylamide gel electrophoresis (SDS–PAGE) and analyzed
by autoradiography as described before (Kato et al., 2004).
Vaccinia virus puriﬁcation and analysis of virus particles
Ten 150-mm dishes containing conﬂuent monolayers of BSC40
cells were infected with either VACV-WR or Cts52 viruses at anMOI of
10 at the permissive or the non-permissive temperature. Infected cells
incubated were for 24 h at 40 °C or for 72 h at 31 °C and harvested for
virus puriﬁcation. Cell-associated virus was puriﬁed by differential
centrifugation through a 36% sucrose cushion followed by banding on
a 24–40% sucrose gradient as previously described (Ausubel et al.,
1994; Kato et al., 2004).
Western blot analysis
Virion core and envelope extracts were prepared and analyzed by
incubating 0.06 A260nm units (0.7 μg) of wt or mutant particles with
core buffer (100 mM DTT and 1% NP40 in 50 mM Tris–HCl pH 8.0) for
30 min at 37 °C. Core and membrane fractions were partitioned by a
15-min centrifugation at 14,000×g. The fractions were resuspended in
SDS sample buffer and the proteins were separated by a 11% SDS–
PAGE and transferred to a nitrocellulose membrane as described
before (Kato et al., 2007). The membrane was blocked with a solution
of TBS-T (50mMTris–HCl pH 7.5; 150mMNaCl; 0.01% Tween 20) and
5% non-fat dry milk (TBS-TM) for 1 h incubated with an appropriate
dilution of the primary antibody in TBS-TM overnight at 8 °C. The
membrane was washed 5 times for 5 min with TBS-T and incubated
with a horseradish-conjugated secondary antibodies (GE Healthcare)
diluted in TBS-TM for 2 h at 8 °C. The membrane was washed 5 times
for 5 min and the protein complex detected by chemiluminescence(GE Healthcare). A His-tag E6 recombinant protein (amino acids 67 to
430) was constructed, puriﬁed, and used as source for raising a rabbit
polyclonal antibody that was prepared by Alpha Diagnostic Interna-
tional and used at a dilution of 1:1000. For the analysis of the RNA
polymerase subunits, unfractionated virions were resuspended in SDS
sample buffer and the proteins were separated by a 10% SDS–PAGE
and processed as described above. The dilution and source of the other
antibodies were the following: anti-L4 (1:40,000) rabbit serum was
supplied by Dr. Dennis Hruby (Oregon State University); anti-H4
(1:5,000) and anti-A29 (1:2,000) rabbit serum was supplied by Dr.
Bernard Moss (NIAID); anti-A10 (1:12,000) and anti-A4 (1:1,000)
rabbit sera were supplied by Dr. Mariano Esteban (Universidad
Autónoma, Madrid); anti-A27 (1:30,000) monoclonal antibody
supplied by Dr. David Ulaeto (Dstl Porton Down, Salisbury); anti-D1
(1:1,000) and anti-D12 (1:6,000) rabbit sera were supplied by Dr.
Edward Niles (SUNY at Buffalo); and anti-J6 (1:2,000) and anti-A24
(1:2,000) rabbit serum supplied by Dr. Stewart Shuman (Sloan-
Kettering Institute).
Electron microscopy
BSC40 cells were infected with either wt or mutant viruses at an
MOI of 10 at permissive or non-permissive temperature. Samples
from 24 to 48 post-infection were prepared for transmission electron
microscopy as described (Kato et al., 2004). The samples were
analyzed with the assistance of the University of Florida ICBR Electron
Microscopy Core Laboratory.
Attachment and entry assay
BSC40 cell monolayers in 8 chamber slides (Lab-Tek) were
infected with 1000 particles per cell for 1 h at 4 °C as described
before (Kato et al., 2007). After the incubation, the unabsorbed virus
was removed, and the cells werewashed oncewith PBS and processed
for virus binding assay or and incubated at 31 °C in DMEM
containing100 μg/ml of cycloheximide for 2 h for entry assay. All
subsequent steps were performed at room temperature. Cells were
ﬁxed with 4% paraformaldehyde in PBS, washed once with PBS,
quenched for 5 min with PBS containing 20 mM glycine, and washed
once again with PBS. Cells were then permeabilized for 2 min with
0.1% Triton X-100, washed twice with PBS, and blocked for 10 min
with PBS containing 10% fetal bovine serum. Antibodies were diluted
in PBS containing 10% fetal bovine serum. Cells were then incubated
for 1 h with anti-A27 antibody for the binding assay or anti-A4
antibody for the entry assay. Cells were washed three times with PBS
and then incubated for 30 min with secondary antibodies. Alexaﬂuor
594 labeled goat-anti-rabbit antibody (Invitrogen) was used as
secondary antibody for visualization of A4; Alexaﬂuor 488 labeled
goat-anti-mouse antibody (Invitrogen) was used as secondary
antibody for A27 visualization. Cells were washed twice with PBS
and stainedwith 0.5 μg/ml DAPI for 15min. Finally, cells were washed
three times with PBS and observed directly on a Leica TCS SP2
Confocal Microscope. Images shown are Z-stacks.
Transcription by permeabilized virions
Virus (0.4 A260nm units) was incubated in a reaction mixture
containing 60 mM Tris–HCl pH 8.0, 0.05% Nonidet P40 (NP40),
10 mM dithiothreitol (DTT), 10 mM MgCl2, 5 mM ATP, 1 mM UTP,
1 mM GTP, and 0.2 mM α-32P-CTP (100 μCi/μmol) at 31 °C as
described previously (Kato et al., 2004). At various times, 50-μl
aliquots were removed, precipitated directly with 5% TCA, ﬁltered
onto a glass microﬁber ﬁlters (934-AH, Whatman), and the
radioactivity was determined by liquid scintillation counting. To
analyze the RNA extruded or core associated, 50-μl aliquots were
230 O. Boyd et al. / Virology 399 (2010) 221–230removed at different time points and centrifuged at 14,000×g for
3 min and the supernatant.
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